AU1093199A - Laminin 5, 13 and 14 and uses thereof - Google Patents

Laminin 5, 13 and 14 and uses thereof

Info

Publication number
AU1093199A
AU1093199A AU10931/99A AU1093199A AU1093199A AU 1093199 A AU1093199 A AU 1093199A AU 10931/99 A AU10931/99 A AU 10931/99A AU 1093199 A AU1093199 A AU 1093199A AU 1093199 A AU1093199 A AU 1093199A
Authority
AU
Australia
Prior art keywords
laminin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10931/99A
Inventor
William Joseph Brunken
Robert Eugene Burgeson
Dale Donald Hunter
Richard Thomas Libby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Tufts University
Original Assignee
General Hospital Corp
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Tufts University filed Critical General Hospital Corp
Publication of AU1093199A publication Critical patent/AU1093199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU10931/99A 1998-10-13 1998-10-15 Laminin 5, 13 and 14 and uses thereof Abandoned AU1093199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10404498P 1998-10-13 1998-10-13
US60104044 1998-10-13
PCT/US1998/021866 WO2000021978A2 (en) 1998-10-13 1998-10-15 Laminin 5, 13 and 14 and uses thereof

Publications (1)

Publication Number Publication Date
AU1093199A true AU1093199A (en) 2000-05-01

Family

ID=22298382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10931/99A Abandoned AU1093199A (en) 1998-10-13 1998-10-15 Laminin 5, 13 and 14 and uses thereof

Country Status (4)

Country Link
EP (1) EP1383530A4 (en)
JP (1) JP2004500012A (en)
AU (1) AU1093199A (en)
WO (1) WO2000021978A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019078781A1 (en) * 2017-10-17 2019-04-25 National University Of Singapore Systems and methods for producing photoreceptor progenitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681587A (en) * 1995-10-06 1997-10-28 Desmos, Inc. Growth of adult pancreatic islet cells
EP0889743A1 (en) * 1996-03-29 1999-01-13 Desmos, Inc. Cellular attachment to laminin 5-coated trans-epithelial appliances
EP0954328A4 (en) * 1996-06-05 2002-07-17 Gen Hospital Corp Laminin-5 and the formation of basement membrane structure

Also Published As

Publication number Publication date
EP1383530A2 (en) 2004-01-28
JP2004500012A (en) 2004-01-08
WO2000021978A2 (en) 2000-04-20
WO2000021978A3 (en) 2003-11-13
EP1383530A4 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
AU4208799A (en) Interleukins-21 and 22
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU4565197A (en) Colostrinin, and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU4496800A (en) Laminin 2 and methods for its use
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU4198299A (en) Compounds and uses thereof
AU4217299A (en) Pth1r and pth3r receptors, methods and uses thereof
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
PL348668A1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
GB9608488D0 (en) Compositions, processes and uses
GB9608485D0 (en) Compositions, processes and uses
AU3830799A (en) Molecular rod and uses
AU3719899A (en) Polymers and their uses
AU4678400A (en) Laminin 8 and methods for its use
AU2001262963A1 (en) Laminin 15 and uses thereof
GB9608489D0 (en) Compositions, processes and uses
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
GB9608491D0 (en) Compositions, processes and uses
GB9706136D0 (en) Compositions,processes and uses
AU5979300A (en) Angiopoietin-6 and uses thereof
AU3283299A (en) Probiotic composition and the use thereof
AU1670800A (en) 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
GB9608487D0 (en) Compositions, processes and uses
GB9705848D0 (en) Compositions, processes and uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase